Page last updated: 2024-11-03

propranolol and Granulomatosis with Polyangiitis

propranolol has been researched along with Granulomatosis with Polyangiitis in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TargoĊ„ska-Stepniak, B1
Majdan, M1

Other Studies

1 other study available for propranolol and Granulomatosis with Polyangiitis

ArticleYear
[Wegener's granulomatosis with subglottic stenosis: options for local and systemic treatment. Review of the literature].
    Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1

    Topics: Adolescent; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; I

2010